![MUHCtalk](http://www.translationalethics.com/wp-content/uploads/2017/04/MUHCtalk.png")
Tuesday, April 18, 2017
12:00 – 1:00pm
RI auditorium, Glen Site – E S1.1129
With the current push to transform Montréal into a hub for early phase research, there is a pressing need to explore the issues that researchers and research ethics boards (REB) encounter in Phase I trials.
In this two-part presentation, recent examples from healthy volunteer and oncology studies will be used to illustrate how protocol design and ethics review can be enhanced.
BibTeX
@Manual{stream2017-1252,
title = {Into the Unknown: Methodological and Ethical Issues in Phase I Trials},
journal = {STREAM research},
author = {Esther Vinarov},
address = {Montreal, Canada},
date = 2017,
month = apr,
day = 17,
url = {http://www.translationalethics.com/2017/04/17/into-the-unknown-methodological-and-ethical-issues-in-phase-i-trials/}
}
MLA
Esther Vinarov. "Into the Unknown: Methodological and Ethical Issues in Phase I Trials" Web blog post. STREAM research. 17 Apr 2017. Web. 04 Dec 2024. <http://www.translationalethics.com/2017/04/17/into-the-unknown-methodological-and-ethical-issues-in-phase-i-trials/>
APA
Esther Vinarov. (2017, Apr 17). Into the Unknown: Methodological and Ethical Issues in Phase I Trials [Web log post]. Retrieved from http://www.translationalethics.com/2017/04/17/into-the-unknown-methodological-and-ethical-issues-in-phase-i-trials/
Leave a Reply